Loading…
Wholesale Pricing for Licensed Professionals
Results update as you type; suggestions appear after 2+ letters.
Asthma
XOLAIR® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in people 18 years of age and older when medicines to treat CRSwNP called nasal corticosteroids have not worked well enough